Home Newsfeeds Keybanc Maintains Overweight on Meta Platforms, Raises Price Target to $196

Keybanc Maintains Overweight on Meta Platforms, Raises Price Target to $196

Keybanc analyst Justin Patterson maintains Meta Platforms (NASDAQ:META) with a Overweight and raises the price target from $190 to $196.

byBenzinga Newsdesk

July 28, 2022

1 minute read

Keybanc analyst Justin Patterson maintains Meta Platforms (NASDAQ:META) with a Overweight and raises the price target from $190 to $196.

FDA Rejects Approval Of Abeona Therapeutics’ Skin Disorder Treatment, Shares Sink

By Vandana Singh

April 23, 9:43 AM

Abeona Therapeutics' pz-cel gets the FDA's Complete Response Letter and Abeona's plans for fulfilling Chemistry Manufacturing and Controls requirements.

ABEO

Apple Unveils AI Tool That Makes Detailed Edits To Videos With Text Commands: Here’s How It Works

By Benzinga Neuro

February 8, 9:05 AM

MGIE uses multimodal language models to interpret user prompts and then 'imagines' what the edit would look like.

AAPL

CrowdStrike To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Tuesday

By Lisa Levin

November 21, 8:47 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

US Proposes Hefty Safety Violation Fine On GM Joint Venture Plant: Report

By Shivani Kumaresan

October 12, 2:16 PM

U.S. investigators have reportedly proposed a substantial fine on a joint venture battery plant in Ohio, operated by General Motors Company (NYSE: GM) and LG Energy Solution in light of safety and health infringements.

Keybanc Maintains Overweight on Meta Platforms, Raises Price Target to $196

Related Posts

FDA Rejects Approval Of Abeona Therapeutics’ Skin Disorder Treatment, Shares Sink

Apple Unveils AI Tool That Makes Detailed Edits To Videos With Text Commands: Here’s How It Works

CrowdStrike To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Tuesday

US Proposes Hefty Safety Violation Fine On GM Joint Venture Plant: Report